2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73780):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-Y1100S1
    Cyclopropylmethyl bromide-d3 1219799-17-3 98%
    Cyclopropylmethyl bromide-d3 is the deuterium labeled Cyclopropylmethyl bromide (HY-Y1100). Cyclopropylmethyl bromide is an intermediate. Cyclopropylmethyl bromide can be used in the preparation of Firocoxib (HY-14670). Firocoxib (ML 1785713) is a potent, selective, orally active COX-2 inhibitor.
    Cyclopropylmethyl bromide-d3
  • HY-Y1117S1
    Melamine-13C3 1173022-88-2 98.71%
    Melamine-13C3 is the 13C labeled Melamine. Melamine is a metabolite of cyromazine. Melamine is a intermediate for the synthesis of melamine resin and plastic materials.
    Melamine-13C3
  • HY-Y1164S1
    D-Alanine-3,3,3-N-t-Boc-d4 98%
    D-Alanine-3,3,3-N-t-Boc-d4 is the deuterium labeled D-Alanine-3,3,3-N-t-Boc.
    D-Alanine-3,3,3-N-t-Boc-d4
  • HY-Y1250S1
    Fmoc-Gly-OH-2-13C,15N 285978-12-3 99.55%
    Fmoc-Gly-OH-2-13C,15N (Fmoc-glycine-2-13C,15N) is the 13C,15N labeled Fmoc-Gly-OH (HY-Y1250). Fmoc-Gly-OH (Fmoc glycine) is a Fmoc-protected glycine derivative, can be used for the synthesis of compounds.
    Fmoc-Gly-OH-2-13C,15N
  • HY-Y1250S3
    Fmoc-Gly-OH-13C 175453-19-7 98%
    Fmoc-Gly-OH-13C (Fmoc-glycine-13C) is a 13C-labeled Fmoc-Gly-OH (HY-Y1250). Fmoc-Gly-OH (Fmoc glycine) is a Fmoc-protected glycine derivative, can be used for the synthesis of compounds.
    Fmoc-Gly-OH-13C
  • HY-Y1250S4
    Fmoc-Gly-OH-1-13C 197965-68-7 98%
    Fmoc-Gly-OH-1-13C (Fmoc-glycine-1-13C) is a 13C-labeled Fmoc-Gly-OH (HY-Y1250). Fmoc-Gly-OH (Fmoc glycine) is a Fmoc-protected glycine derivative, can be used for the synthesis of compounds.
    Fmoc-Gly-OH-1-13C
  • HY-Y1250S5
    Fmoc-Gly-OH-13C2 286460-80-8 98%
    Fmoc-Gly-OH-13C2 (Fmoc-glycine-13C2) is a 13C-labeled Fmoc-Gly-OH (HY-Y1250). Fmoc-Gly-OH (Fmoc glycine) is a Fmoc-protected glycine derivative, can be used for the synthesis of compounds.
    Fmoc-Gly-OH-13C2
  • HY-Y1275S1
    N-Methylpyrrolidone-d3 933-86-8 98%
    N-Methylpyrrolidone-d3 is the deuterium labeled N-Methylpyrrolidone . N-Methylpyrrolidone (1-Methyl-2-pyrrolidinone), a five-membered cyclic amide, is an organic polar solvent. N-Methylpyrrolidone is extensively used in the manufacture of adhesives, paints, fuels, and pharmaceuticals.
    N-Methylpyrrolidone-d3
  • HY-Y1298S1
    Methyl acetylacetate-d3 65491-21-6
    Methyl acetylacetate-d3 (Acetoacetate methyl ester-d3) is a deuterium labeled Methyl acetylacetate (HY-Y1298). Methyl acetylacetate is an endogenous metabolite.
    Methyl acetylacetate-d3
  • HY-Y1352S1
    Potassium cyanate-13C,15N 98%
    Potassium cyanate-13C,15N is the 13C and 15N labeled Potassium cyanate.
    Potassium cyanate-13C,15N
  • HY-Z10347S
    Lumateperone metabolite M131-d3 2228997-85-9
    Lumateperone metabolite M131-d3 is the deuterium labeled Lumateperone metabolite M131.
    Lumateperone metabolite M131-d3
  • HY-Z10677S
    Vortioxetine impurity 9-d8
    Vortioxetine impurity 9-d8 is the deuterium labeled Vortioxetine impurity 9. Vortioxetine impurity 9 is an impurity of Vortioxetine (HY-15414).
    Vortioxetine impurity 9-d8
  • HY-Z12315S
    N2-Acetyl acyclovir benzoate-d5
    N2-Acetyl acyclovir benzoate-d5 is the deuterium labeled N2-Acetyl acyclovir benzoate.
    N2-Acetyl acyclovir benzoate-d5
  • HY-Z13357S
    Nifedipine nitroso-d6
    Nifedipine nitroso-d6 is the deuterium labeled Nifedipine nitroso.
    Nifedipine nitroso-d6
  • HY-Z2289S1
    (S)-Ibrutinib-d4
    (S)-Ibrutinib-d4 is the deuterium labeled (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (Ibrutinib Impurity） (HY-Z2289).
    (S)-Ibrutinib-d4
  • HY-10002AS2
    (1S)-Calcitriol-d6 1202355-83-6
    (1S)-Calcitriol-d6 (1α,25-Dihydroxy-3-epi-vitamin D3-d6) is the deuterium labeled (1S)-Calcitriol (HY-10002A). (1S)-Calcitriol (1α,25-Dihydroxy-3-epi-vitamin-D3) is a natural metabolite of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3). (1S)-Calcitriol exhibits potent vitamin D receptor (VDR)-mediated actions such as inhibition of keratinocyte growth or suppression of parathyroid hormone secretion.
    (1S)-Calcitriol-d6
  • HY-100582S1
    Ribitol-2-13C 98.0%
    Ribitol-2-13C is the 13C labeled Ribitol. Ribitol is a crystalline pentose alcohol formed by the reduction of ribose. Enhancing the flux of D-glucose to the pentose phosphate pathway in Saccharomyces cerevisiae for the production of D-ribose and ribitol
    Ribitol-2-13C
  • HY-100582S2
    Ribitol-3-13C 99.70%
    Ribitol-3-13C is the 13C labeled Ribitol. Ribitol is a crystalline pentose alcohol formed by the reduction of ribose. Enhancing the flux of D-glucose to the pentose phosphate pathway in Saccharomyces cerevisiae for the production of D-ribose and ribitol
    Ribitol-3-13C
  • HY-100582S3
    Ribitol-5-13C 98%
    Ribitol-5-13C is the 13C labeled Ribitol. Ribitol is a crystalline pentose alcohol formed by the reduction of ribose. Enhancing the flux of D-glucose to the pentose phosphate pathway in Saccharomyces cerevisiae for the production of D-ribose and ribitol
    Ribitol-5-13C
  • HY-101108S1
    Tazarotenic acid-13C2,d2 1309935-88-3 98%
    Tazarotenic acid-13C2,d2 (AGN 190299-13C2,d2) is the 13C and deuterium labeled isotope of Tazarotenic acid (HY-101108). Tazarotenic acid is the metabolite of Tazarotene. Tazarotenic acid binding to retinoic acid receptors (RARs) is the probable molecular target of retinoid action. Tazarotenic acid has the potential for the research of warty dyskeratoma.
    Tazarotenic acid-13C2,d2